February 06, 2026 a 01:00 pm

DHR: Fundamental Ratio Analysis - Danaher Corporation

Danaher Corporation Stock Analysis

Danaher Corporation's stock exhibits steady growth potential in the healthcare sector. With a diverse range of products across life sciences, diagnostics, and environmental solutions, the company is well-positioned to capitalize on industry advancements. However, investors should be mindful of market fluctuations and sector-specific challenges.

Fundamental Rating

The fundamental analysis of Danaher Corporation indicates a stable performance with strengths in specific ratios.

Category Score Visualization
Discounted Cash Flow 4
Return on Equity 3
Return on Assets 4
Debt to Equity 2
Price to Earnings 1
Price to Book 2

Historical Rating

The historical scores reflect the consistency and areas of improvement in the company's financial health over time.

Date Overall DCF ROE ROA Debt/Equity P/E P/B
2026-02-05 3 4 3 4 2 1 2
Prior 0 4 3 4 2 1 2

Analyst Price Targets

Analyst price targets illustrate market confidence and potential stock growth.

High Low Median Consensus
$270 $220 $254 $252.33
Danaher Stock Chart

Analyst Sentiment

The analyst sentiment reflects a positive outlook, with a majority recommending a "Buy".

Recommendation Number Visualization
Strong Buy 1
Buy 30
Hold 10
Sell 1
Strong Sell 0

Conclusion

Danaher Corporation demonstrates a balanced mix of strengths and weaknesses in its financial performance, with significant potential in its core sectors. While its market position provides stability, challenges such as fluctuating market conditions and sector-specific hurdles should be considered. Overall, the stock is generally viewed positively, especially in long-term prospects. The company’s steady innovation in healthcare solutions continues to bolster its reputation. Investors are advised to monitor market trends closely.